Since MIN6 cells are insulin-secreting tumor cells [16] that proliferate and secrete insulin autonomously in vivo [19,23], all of our nude mouse recipients experienced hypoglycemia within 2 weeks after implantation of MIN6 cells embedded in Matrigel. The gene discussed is INS; the disease is Hypoglycemia.